Montpellier, France

Jean-Francois Eliaou

USPTO Granted Patents = 5 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Montpellier, FR (2017 - 2019)
  • Creteil, FR (2020 - 2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Jean-Francois Eliaou

Introduction

Jean-Francois Eliaou is a prominent inventor based in Montpellier, France, known for his remarkable contributions to the field of medical research. With a total of five patents to his name, Eliaou has made significant strides in developing innovative solutions for health-related challenges, particularly in the area of cancer and infectious diseases.

Latest Patents

Among his notable inventions, Jean-Francois Eliaou's latest patents focus on antibodies against human CD39. These antibodies are designed to inhibit the activity of T regulatory cells (Treg), which play a crucial role in immune regulation. The invention holds potential for the treatment and prevention of cancers and various infectious diseases, marking a substantial advancement in therapeutic options available for these conditions.

Career Highlights

Throughout his career, Eliaou has contributed to significant research initiatives and projects. He has been associated with prestigious organizations such as the Institut National de la Santé et de la Recherche Médicale (INSERM) and Orega Biotech. His tenure at these institutions not only highlights his commitment to medical innovation but also showcases his expertise in bridging research and practical applications.

Collaborations

Eliaou's journey has been enriched by collaborations with esteemed professionals in the field. Notable coworkers, such as Armand Bensussan and Gilles Alberici, have partnered with him on various projects, fostering an environment of innovation and shared knowledge. These collaborations have played a crucial role in advancing research and generating impactful outcomes in medical science.

Conclusion

Jean-Francois Eliaou stands out as an influential inventor whose work is paving the way for future advancements in medical treatments. His dedication to harnessing the power of antibodies against human CD39 exemplifies the potential of innovative research in tackling some of the most challenging health issues today. With his continuous contributions, Eliaou is undeniably making a mark in the world of science and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…